Filing Flows › Milestone Pharmaceuticals (MIST) › Recalls, complaints & regulation
Milestone Pharmaceuticals (MIST): recalls, EPA violations and clinical trials
Milestone Pharmaceuticals (MIST) beyond its filings: 1 recall in the last 12 months (1 in five years, 0 Class I); 2 EPA-regulated facilities in violation, $10K in penalties over five years; 2 active clinical trials.
Latest recalls
- 2026-05-06 · FDA device · VACUUM BAG SU LARGE, Non-sterile specimen container, Model/Catalog Number: 68409SS
EPA facilities in violation
| Facility (as registered) | City | Status | Penalties |
|---|---|---|---|
| MILESTONE AV TECHNOLOGIES LLC DBA DALIT | Warsaw, IN | Significant Violation | — |
| MILESTONE CONTRACTORS | Ridgeville, IN | Violation Identified | — |
Facilities in the EPA's ECHO register whose registered name matches the company's; a facility can belong to another business of the same name.
Milestone Pharmaceuticals' latest quarter
Milestone Pharmaceuticals, Q2 2026: revenue $559K, net loss $28.6M, operating cash flow −$22.7M. The chart follows the revenue to costs, profit and cash.
Questions
Has Milestone Pharmaceuticals had any recalls?
1 recall on file over five years from the FDA, CPSC and NHTSA; 1 in the last 12 months.
Has Milestone Pharmaceuticals been fined by the EPA?
The 52 EPA-regulated facilities on file under its name drew $10K in penalties over five years; 2 are in violation now.
How many clinical trials does Milestone Pharmaceuticals have?
2 active studies on ClinicalTrials.gov, 1 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.